Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-17-017199
Filing Date
2017-03-16
Accepted
2017-03-16 17:21:00
Documents
81
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a17-1159_110k.htm 10-K 1897949
2 EX-21.1 a17-1159_1ex21d1.htm EX-21.1 1538
3 EX-23.1 a17-1159_1ex23d1.htm EX-23.1 5591
4 EX-31.1 a17-1159_1ex31d1.htm EX-31.1 11752
5 EX-31.2 a17-1159_1ex31d2.htm EX-31.2 11585
6 EX-32.1 a17-1159_1ex32d1.htm EX-32.1 5209
7 EX-32.2 a17-1159_1ex32d2.htm EX-32.2 5201
14 GRAPHIC g11591cui001.jpg GRAPHIC 27621
  Complete submission text file 0001104659-17-017199.txt   7861063

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT stml-20161231.xml EX-101.INS 1808498
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20161231.xsd EX-101.SCH 54660
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20161231_cal.xml EX-101.CAL 55005
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20161231_def.xml EX-101.DEF 177679
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20161231_lab.xml EX-101.LAB 539746
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20161231_pre.xml EX-101.PRE 361861
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

EIN.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35619 | Film No.: 17695546
SIC: 2834 Pharmaceutical Preparations